Clinical Trial Update: Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight Gain [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating betahistine for efficacy and tolerability in reducing antipsychotic-associated weight gain; the study is completed and results were pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder
• Bipolar Disorder
• Bipolar Disorder Unspecified
• Bipolar Ii Disorder
• Psychotic Disorder Not Otherwise Specified
• Schizoaffective Disorder
• Schizophrenia
• Schizophreniform Disorder

Drugs mentioned

• Betahistine (betahistine)

Snippet

Sponsor: Nathan Kline Institute for Psychiatric Research | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 2 | Status: COMPLETED | Results posted: 2019-01-25